C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
167/231, 260/278
C07D 401/02 (2006.01) A61K 31/445 (2006.01) C07D 401/06 (2006.01) C07D 401/14 (2006.01)
Patent
CA 1332239
Abstract of the Disclosure The present invention provides novel tetrazole derivatives useful as excitatory amino acid receptor antagonists and in treating a variety of associated nervous system disorders. The novel tetrazole derivatives are compounds of the formula Image I wherein: R1 is -?OR3, -?N(R4)2, Image , Image or Image ; R2 is hydrogen or C1-C3 alkyl; n is 0, 1, 2 or 3; m is 0 or 1; provided that the sum of m and n is 0, 1, 2 or 3; R3 is hydrogen, C1-C4 alkyl, phenyl or an oral ester forming group; Y is -CH=; and each R4 is independently hydrogen, C1-C4 alkyl or phenyl; or pharmaceutically acceptable salts thereof.
590966
Eli Lilly And Company
Gowling Lafleur Henderson Llp
LandOfFree
Tetrazole excitatory amino acid receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tetrazole excitatory amino acid receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tetrazole excitatory amino acid receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1340766